Validity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study
Launched by UNIVERSITY OF TURKU ·
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new, non-invasive ways to detect a heart rhythm problem called supraventricular tachycardia (SVT) in children from birth up to 10 years old. SVT causes the heart to beat very fast, which can be uncomfortable and sometimes serious. The study will test two methods: using a smartphone to pick up heart signals through chest movements (seismocardiography) and a special sensor placed in the bed to detect heartbeats (ballistocardiography). These will be compared to the usual, more detailed heart monitoring with an ECG, which records the heart’s electrical activity continuously.
Children from any gender who are between 0 and 10 years old may be eligible to participate. If selected, families can expect their child to be monitored using the smartphone and bed sensors, while also having the standard ECG test to check how well the new methods work. This study is still in the early stages and not yet enrolling participants, but it aims to develop easier and more comfortable ways to detect fast heart rhythms in young children, which could help with quicker diagnosis and treatment in the future.
Gender
ALL
Eligibility criteria
About University Of Turku
The University of Turku, established in 1920, is a leading research institution located in Finland, renowned for its commitment to advancing knowledge and innovation across various fields. As a clinical trial sponsor, the university leverages its extensive expertise and collaborative networks to conduct rigorous and ethically sound research, aiming to improve healthcare outcomes and contribute to scientific advancements. With a focus on interdisciplinary approaches, the University of Turku fosters an environment that encourages groundbreaking studies, ultimately enhancing the quality of life through evidence-based medical solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported